• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依前列醇在姑息治疗环境中的肺动脉高压治疗。

Epoprostenol use for pulmonary arterial hypertension in the palliative care setting.

机构信息

Department of Internal Medicine, Division of General Medicine, Virginia Commonwealth University, Richmond, Virginia 23298, USA.

出版信息

J Palliat Med. 2012 May;15(5):619-22. doi: 10.1089/jpm.2011.0182. Epub 2012 Mar 6.

DOI:10.1089/jpm.2011.0182
PMID:22394366
Abstract

Prostacyclin analogues such as epoprostenol (Flolan®) are commonly used in the treatment of pulmonary arterial hypertension (PAH). However, their complex administration and significant cost may limit the access that patients with PAH have to palliative and hospice care. We herein report our experience using epoprostenol in a dedicated palliative care unit and present our inpatient protocol for the drug's administration.

摘要

前列环素类似物,如依前列醇(Flolan®),常用于治疗肺动脉高压(PAH)。然而,其复杂的给药方式和高昂的费用可能会限制 PAH 患者获得姑息治疗和临终关怀的机会。本文报告了我们在专门的姑息治疗病房中使用依前列醇的经验,并介绍了该药的住院治疗方案。

相似文献

1
Epoprostenol use for pulmonary arterial hypertension in the palliative care setting.依前列醇在姑息治疗环境中的肺动脉高压治疗。
J Palliat Med. 2012 May;15(5):619-22. doi: 10.1089/jpm.2011.0182. Epub 2012 Mar 6.
2
Differential response to intravenous prostacyclin analog therapy in patients with pulmonary arterial hypertension.肺动脉高压患者对静脉内前列环素类似物治疗的反应差异。
Pulm Pharmacol Ther. 2011 Aug;24(4):421-5. doi: 10.1016/j.pupt.2011.01.002. Epub 2011 Jan 18.
3
Epoprostenol (Veletri®, Caripul®): a review of its use in patients with pulmonary arterial hypertension.依前列醇(Veletri®,Caripul®):其在肺动脉高压患者中的应用综述
Am J Cardiovasc Drugs. 2014 Dec;14(6):463-70. doi: 10.1007/s40256-014-0093-0.
4
Epoprostenol for primary pulmonary hypertension.依前列醇用于原发性肺动脉高压
Med Lett Drugs Ther. 1996 Feb 16;38(968):14-5.
5
A new epoprostenol formulation for the treatment of pulmonary arterial hypertension.一种新型依前列醇制剂,用于治疗肺动脉高压。
Am J Health Syst Pharm. 2012 Aug 15;69(16):1389-93. doi: 10.2146/ajhp110687.
6
Cost effectiveness of prostacyclins in pulmonary arterial hypertension.前列腺素类药物治疗肺动脉高压的成本效益。
Appl Health Econ Health Policy. 2012 May 1;10(3):175-88. doi: 10.2165/11630780-000000000-00000.
7
Prostacyclin therapy for pulmonary arterial hypertension: new directions.前列环素治疗肺动脉高压:新方向
Semin Respir Crit Care Med. 2005 Aug;26(4):394-401. doi: 10.1055/s-2005-916154.
8
One-year experience with intravenous treprostinil for pulmonary arterial hypertension.静脉注射曲前列尼尔治疗肺动脉高压一年的经验。
J Heart Lung Transplant. 2013 Sep;32(9):889-96. doi: 10.1016/j.healun.2013.06.008.
9
Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)-An open-label, single-arm study.新型更耐热福莫特罗(前列环素)制剂在日本肺动脉高压(PAH)患者中的安全性和疗效研究 - 一项开放标签、单臂研究。
PLoS One. 2018 Apr 2;13(4):e0195195. doi: 10.1371/journal.pone.0195195. eCollection 2018.
10
[Progress in pharmacotherapy of pulmonary arterial hypertension in children].[儿童肺动脉高压的药物治疗进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2012 Mar;14(3):236-40.

引用本文的文献

1
A World of Maximalist Medicine: Physician Perspectives on Palliative Care and End-of-life for Patients With Pulmonary Arterial Hypertension.极度医疗化的世界:肺高血压患者的姑息治疗和临终关怀的医师观点。
J Pain Symptom Manage. 2023 Apr;65(4):e329-e335. doi: 10.1016/j.jpainsymman.2022.11.027. Epub 2022 Dec 13.